Sieswerda, E;
Boer, M.G.J. de;
Bonten, M. M. J;
Boersma, W. G;
Jonkers, R. E;
Aleva, R. M;
Kullberg, B. J;
Schouten, J. A;
van de Garde, E.M. W;
Verheij, T. J;
van der Eerden, M. M;
Prins, J. M;
Wiersinga, W. J.
The Dutch Working Party on Antibiotic Policy constituted a multidisciplinary expert committee to provide evidence-based recommendation for the use of antibacterial therapy in hospitalized adults with a respiratory infection and suspected or proven 2019 Coronavirus disease (COVID-19). We performed a liter...
Jin, Ying-Hui;
Zhan, Qing-Yuan;
Peng, Zhi-Yong;
Ren, Xue-Qun;
Yin, Xun-Tao;
Cai, Lin;
Yuan, Yu-Feng;
Yue, Ji-Rong;
Zhang, Xiao-Chun;
Yang, Qi-Wen;
Ji, Jianguang;
Xia, Jian;
Li, Yi-Rong;
Zhou, Fu-Xiang;
Gao, Ya-Dong;
Yu, Zhui;
Xu, Feng;
Tu, Ming-Li;
Tan, Li-Ming;
Yang, Min;
Chen, Fang;
Zhang, Xiao-Ju;
Zeng, Mei;
Zhu, Yu;
Liu, Xin-Can;
Yang, Jian;
Zhao, Dong-Chi;
Ding, Yu-Feng;
Hou, Ning;
Wang, Fu-Bing;
Chen, Hao;
Zhang, Yong-Gang;
Li, Wei;
Chen, Wen;
Shi, Yue-Xian;
Yang, Xiu-Zhi;
Wang, Xue-Jun;
Zhong, Yan-Jun;
Zhao, Ming-Juan;
Li, Bing-Hui;
Ma, Lin-Lu;
Zi, Hao;
Wang, Na;
Wang, Yun-Yun;
Yu, Shao-Fu;
Li, Lu-Yao;
Huang, Qiao;
Weng, Hong;
Ren, Xiang-Ying;
Luo, Li-Sha;
Fan, Man-Ru;
Huang, Di;
Xue, Hong-Yang;
Yu, Lin-Xin;
Gao, Jin-Ping;
Deng, Tong;
Zeng, Xian-Tao;
Li, Hong-Jun;
Cheng, Zhen-Shun;
Yao, Xiaomei;
Wang, Xing-Huan.
The novel severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is the cause of a rapidly spreading illness,
coronavirus disease 2019 (COVID-19), affecting more than seventeen million people around the world. Diagnosis
and treatment guidelines for clinicians caring for patients are needed. In the ...
Chemoprevention/methods,
Coronavirus Infections/diagnosis,
Coronavirus Infections/drug therapy,
Pneumonia, Viral/diagnosis,
Pneumonia, Viral/drug therapy,
Pandemics/prevention & control,
Betacoronavirus/drug effects,
Evidence-Based Practice/methods,
Anti-Retroviral Agents/therapeutic use,
Lopinavir/therapeutic use,
Chloroquine/therapeutic use,
Receptors, Interleukin-6/therapeutic use,
Hydroxychloroquine/therapeutic use,
Plasma/immunology
Rochwerg, Bram;
Agarwal, Arnav;
Zeng, Linan;
Leo, Yee-Sin;
Appiah, John Adabie;
Agoritsas, Thomas;
Bartoszko, Jessica;
Brignardello-Petersen, Romina;
Ergan, Begum;
Ge, Long;
Geduld, Heike;
Gershengorn, Hayley B;
Manai, Hela;
Huang, Minhua;
Lamontagne, François;
Kanda, Seema;
Kawano-Dourado, Leticia;
Kurian, Linda;
Kwizera, Arthur;
Murthy, Srinivas;
Qadir, Nida;
Siemieniuk, Reed;
Silvestre, Maria Asuncion;
Vandvik, Per Olav;
Ye, Zhikang;
Zeraatkar, Dena;
Guyatt, Gordon.
Clinical question: What is the role of remdesivir in the treatment of severe covid-19? This guideline was triggered by the ACTT-1 trial published in the New England Journal of Medicine on 22 May 2020.Remdesivir has received worldwide attention as a potentially effective treatment for severe covid-19. Aft...
A potentially severe acute respiratory infection caused by the novel coronavirus severe acute respiratory
syndrome coronavirus 2 (SARS-CoV-2).[1] The clinical presentation is generally that of a respiratory infection
with a symptom severity ranging from a mild common cold-like illness, to a severe viral ...
Betacoronavirus/pathogenicity,
Coronavirus Infections/diagnostic imaging,
Coronavirus Infections/complications,
Coronavirus Infections/drug therapy,
Pneumonia, Viral/diagnostic imaging,
Pneumonia, Viral/drug therapy,
Pneumonia, Viral/complications,
Pandemics/statistics & numerical data,
Symptom Flare Up,
Risk Groups,
China/epidemiology,
Healthcare-Associated Pneumonia/diagnosis,
Health Personnel/organization & administration,
Carrier State/transmission,
Infectious Disease Transmission, Vertical/prevention & control
Moores, Lisa K;
Tritschler, Tobias;
Brosnahan, Shari;
Carrier, Marc;
Collen, Jacob F;
Doerschug, Kevin;
Holley, Aaron B;
Jimenez, David;
Gal, Gregoire Le;
Rali, Parth;
Wells, Philip.
Emerging evidence shows that severe coronavirus disease 2019 (COVID-19) can be complicated by a significant coagulopathy, that likely manifests in the form of both microthrombosis and VTE. This recognition has led to the urgent need for practical guidance regarding prevention, diagnosis, and treatment of...
Chawla, Deepak;
Chirla, Dinesh;
Dalwai, Samir;
deorari, Ashok K;
Ganatra, Atul;
Gandhi, Alpesh;
Kabra, Nandkishor S;
Kumar, Praveen;
Mittal, Pratima;
Parekh, Bakul Jayant;
Sankar, M Jeeva;
Singhal, Tanu;
Sivanandan, Sindhu;
Tank, Parikshit.
During the current rapidly evolving pandemic of COVID-19 infection, pregnant women with suspected or confirmed COVID-19 and their newborn infants form a special vulnerable group that needs immediate attention. Unlike other elective medical and surgical problems for which care can be deferred during the p...
Betacoronavirus,
Coronavirus Infections/complications,
Coronavirus Infections/embryology,
Pneumonia, Viral/complications,
Pneumonia, Viral/embryology,
Maternal and Child Health,
Perinatal Care/organization & administration,
Pregnancy Complications, Infectious/prevention & control
Desde sua identificação na China em dezembro de 2019, o novo coronavírus responsável pela COVID-19 evoluiu rapidamente para uma pandemia. A COVID-19 se manifesta com sintomas respiratórios inespecíficos de gravidade variável e pode exigir suporte respiratório avançado. Atualmente, o diagnóstico...
Falavigna, Maicon;
Colpani, Verônica;
Stein, Cinara;
Azevedo, Luciano César Pontes;
Bagattini, Ângela Maria;
Brito, Gabriela Vilela de;
Chatkin, José Miguel;
Cimerman, Sérgio;
Corradi, Mirian de Freitas Dal Ben;
Cunha, Clóvis Arns da;
Medeiros, Flávia Cordeiro de;
Oliveira Júnior, Haliton Alves de;
Fritscher , Leandro Genehr;
Gazzana, Marcelo Basso;
Graf, Débora Dalmas;
Marra, Lays Pires;
Matuoka , Jéssica Yumi;
Nunes, Michelle Silva;
Pachito, Daniela Vianna;
Pagano, Cássia Garcia Moraes;
Parreira, Patrícia do Carmo Silva;
Riera, Rachel;
Silva Júnior, Amilton;
Tavares, Bruno de Melo;
Zavascki, Alexandre Prehn;
Rosa, Régis Goulart;
Dal-Pizzol, Felipe.
Different therapies are currently used, considered, or proposed for the treatment of COVID-19; for many of those therapies, no appropriate assessment of effectiveness and safety was performed. This document aims to provide scientifically available evidence-based information in a transparent interpretatio...
Coronavirus Infections/drug therapy,
Aminoquinolines/therapeutic use,
Oseltamivir/therapeutic use,
Lopinavir/therapeutic use,
Ritonavir/therapeutic use,
Adrenal Cortex Hormones/therapeutic use,
Heparin/therapeutic use,
Anti-Bacterial Agents/therapeutic use,
Betacoronavirus/drug effects,
Pneumonia, Viral/drug therapy,
Pandemics/prevention & control
The purpose of this guideline is to maximise the safety of adults with chronic kidney disease during the COVID-19 pandemic. It also aims to protect staff from infection and enable services to make the best use of NHS resources....
Renal Insufficiency, Chronic/nursing,
Renal Insufficiency, Chronic/diagnosis,
Renal Insufficiency, Chronic/prevention & control,
Betacoronavirus,
Coronavirus Infections/complications,
Pneumonia, Viral/complications,
Kidney/diagnostic imaging
The purpose of this guideline is to maximise the safety of adults with interstitial lung disease, including idiopathic pulmonary fibrosis and pulmonary sarcoidosis, during the COVID-19 pandemic. It also aims to protect staff from infection and enable services to make the best use of NHS resources....
